tiprankstipranks
Glaukos price target raised to $102 from $90 at BTIG
PremiumThe FlyGlaukos price target raised to $102 from $90 at BTIG
2M ago
Glaukos price target raised to $103 from $83 at Wells Fargo
PremiumThe Fly
Glaukos price target raised to $103 from $83 at Wells Fargo
2M ago
Glaukos price target raised to $107 from $101 at Citi
PremiumThe Fly
Glaukos price target raised to $107 from $101 at Citi
2M ago
Glaukos backs FY24 revenue view $350M-$360M, consensus $352.71M
PremiumThe FlyGlaukos backs FY24 revenue view $350M-$360M, consensus $352.71M
4M ago
Glaukos raises FY23 revenue view to $313M from $307M-$310M, consensus $309.02M
PremiumThe Fly
Glaukos raises FY23 revenue view to $313M from $307M-$310M, consensus $309.02M
4M ago
Glaukos reports preliminary Q4 revenue $81M, consensus $76.66M
PremiumThe Fly
Glaukos reports preliminary Q4 revenue $81M, consensus $76.66M
4M ago
Glaukos upgraded to Overweight from Neutral at JPMorgan
PremiumThe FlyGlaukos upgraded to Overweight from Neutral at JPMorgan
4M ago
Glaukos announces FDA approval of iDose TR
PremiumThe Fly
Glaukos announces FDA approval of iDose TR
4M ago
GM upgraded, Lululemon downgraded: Wall Street’s top analyst calls
PremiumThe Fly
GM upgraded, Lululemon downgraded: Wall Street’s top analyst calls
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100